NCT01033526

Symptomatic Treatment of Common Cold Symptoms

A Two-arm, Multicenter, Randomized, Double-blind, Single Dose Placebo-controlled Parallel Groups Study Evaluating Efficacy and Tolerability of 800 mg Acetylsalicylic Acid (Aspirina® C) in Adult Patients With a Common Cold During a Two Hour in Patient Phase; and a Follow-up Period of Five Days of Home Treatment as Required

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 388 (actual)
• Sponsor: Bayer · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

A two-arm, multicenter, randomized, double-blind, single dose placebo-controlled parallel groups study evaluating efficacy and tolerability of 800 mg Acetylsalicylic Acid (Aspirina C) in adult patients with a common cold during a two hour in patient phase; and a follow-up period of five days of home treatment as required.

Conditions

• Common Cold

Interventions

Type	Name	Description
DRUG	Aspirin (Acetylsalicylic acid, BAYE4465)	1-2 tablets Acetylsalicylic Acid 400 mg (in combination with Ascorbic Acid 240 mg) as needed every 4-6 hours over a maximum of 5 days
DRUG	Placebo	1-2 tablets matching Placebo as needed every 4-6 hours over a maximum of 5 days

Timeline

• Start date: 2005-10-01
• Completion: 2007-06-01
• First posted: 2009-12-16
• Last updated: 2009-12-16

Locations

28 sites across 1 country: Italy